Frontlight ResearchEarly access
Trial site
Changhua Christian Medical Foundation Changhua Christian Hospital
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Head and neck cancer2 trials
- Lung cancer2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Alzheimer disease1 trial
- Gastric and oesophageal cancer1 trial
- Haemophilia1 trial
- Lupus (SLE)1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 36 trials
- Phase 2/32 trials
- Phase 1/21 trial
- Status
- Active, not recruiting6 trials
- Completed1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Biogen2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Alentis Therapeutics AG1 trial
- BioMarin Pharmaceutical1 trial
- Gilead Sciences1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Lung cancer1 recruiting
Closed trials
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026